Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
|
|
- Cassandra Parsons
- 5 years ago
- Views:
Transcription
1 Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
2 Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or reportstore@bioportfolio.com 2
3 Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Becton, Dickinson and Company (BD) is a medical technology company that manufactures and sells medical devices, reagents and instrument systems for life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry and general public. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management systems; prefillable drug delivery systems; respiratory ventilation and diagnostics equipment and consumables; products for the safe collection and transport of diagnostics specimens; instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infectionsand cancers and various clinical research tools. The company through BD Technologies conducts research and development activities to improve manufacturing and process methods. The company sells its in the Americas, Europe, the Middle East, Africa, Asia Pacific. BD is headquartered in New Jersey, the US. Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. 3
4 - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH511D Number of Pages : 85 Report Format : PDF 4
5 Publisher Information : 5
6 Table Of Contents for Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 4List of Figures 6Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Becton, Dickinson and Company, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD Becton, Dickinson and Company, Medical Devices Deals, 2010 to YTD Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deal Details 17Venture Financing 17GenCell Biosystems Raises US$3.5 Million In Seed Financing Round 17Sirigen Secures US$3 Million In Venture Financing 18Sirigen Secures US$6.13 Million In Venture Financing 20Accuri Cytometers Secures US$6 Million In Series E Preferred Stock Financing Round 22Private Equity 23Apax Partners to Acquire 50.1% Stake in Respiratory Solutions Business of Becton, Dickinson 23CareFusion Reportedly Elicits Acquisition Interest From Private Equity Firms 24Partnerships 25Selah Genomics, Greenville Health, DecisionQ and Becton Dickinson Enter into Agreement 25GenCell Biosystems To Enter Into Agreement With Fiocruz, Institute Of Molecular Biology Of Parana And Immunobiological Technology Institute To Develop Clinical Screening Systems 26Sartorius Stedim Biotech Enters Into Co-Development Agreement With BD Diagnostic 27NanoString Technologies And BD Biosciences Enter Into Agreement To Develop Single Cell Isolation And Analysis Workflow 28TCGRx Enters Into Co-Marketing Agreement With CareFusion For Medication Delivery Solutions 30CareFusion Enters Into Distribution Agreement With ResMed 31SANYO North America Enters Into Co-Promotion Agreement With BD Biosciences 32Accuri Cytometers Enters Into Co-Marketing Agreement With ebioscience 33Bruker Daltonics And KIESTRA Enter Into Co-Marketing Agreement 34Licensing Agreements 35Advanced Inhalation Therapies Enters into Licensing Agreement with CareFusion 35BD Diagnostic Systems Enters Into Licensing Agreement With Lonza Group 36Fate Therapeutics Enters Into Licensing Agreement With Becton, Dickinson 37CareFusion Enters Into Licensing Agreement With Healthpoint 39Eurogentec Enters Into Licensing Agreement With BD Diagnostics 40Caliper Life Sciences Enters Into Licensing Agreement With BD Biosciences 41Equity Offering 42Becton, Dickinson Files Registration Statement For Public Offering Of Securities 42Debt Offering 43Becton, Dickinson Raises USD1.2 Billion in Public Offering of 4.685% Notes Due Becton, Dickinson Raises USD1.75 Billion in Public Offering of 3.734% Notes Due Becton, Dickinson Raises USD750 Million in Public Offering of Floating Rate Notes Due Becton, Dickinson Raises USD1.25 Billion in Public Offering of 2.675% Notes Due Becton, Dickinson Raises USD1.25 Billion in Public Offering of 1.8% Notes Due CareFusion Raises USD300 Million in Public Offering of Notes Due CareFusion Raises USD300 Million in Private Placement of Notes Due CareFusion Raises USD400 Million in Public Offering of Notes Due CareFusion Completes Private Placement Of Notes Due 2023 For US$300 Million 59Becton, Dickinson Completes Public Offering Of Notes Due 2016 For US$500 Million 60Becton, Dickinson Completes Public Offering Of Notes Due 2021 For US$1 Billion 61Becton, Dickinson and Company Completes Underwritten Public Offering Of Senior Unsecured Notes Due 2040 For US$300 Million 63Becton, Dickinson Completes Underwritten Public Offering Of Senior Unsecured Notes Due 2020 For US$700 Million 64Asset Transactions 65Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 65eResearchTechnology Acquires Research Services Division From CareFusion 66Acquisition 68BD Acquires CRISI Medical Systems 68Becton, Dickinson Acquires GenCell Biosystems 69Becton, Dickinson Acquires Sirigen, Developer Of Polymer Dyes 70Becton, Dickinson Acquires KIESTRA, Provider Of Lab Automation Solutions 72CareFusion Completes Acquisition Of Medegen From Nautic Partners 73Becton, Dickinson and Company - Key Competitors 75Key Employees 76Locations And Subsidiaries 78Head Office 78Other Locations & Subsidiaries 78Appendix 85Methodology 85About GlobalData 85Contact Us 85Disclaimer 85 6
7 List Of Tables in Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Key Facts, Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Becton, Dickinson and Company, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Becton, Dickinson and Company, Deals By Therapy Area, 2010 to YTD Becton, Dickinson and Company, Medical Devices Deals, 2010 to YTD Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD GenCell Biosystems Raises US$3.5 Million In Seed Financing Round 17 Sirigen Secures US$3 Million In Venture Financing 18 Sirigen Secures US$6.13 Million In Venture Financing 20 Accuri Cytometers Secures US$6 Million In Series E Preferred Stock Financing Round 22 Apax Partners to Acquire 50.1% Stake in Respiratory Solutions Business of Becton, Dickinson 23 CareFusion Reportedly Elicits Acquisition Interest From Private Equity Firms 24 Selah Genomics, Greenville Health, DecisionQ and Becton Dickinson Enter into Agreement 25 GenCell Biosystems To Enter Into Agreement With Fiocruz, Institute Of Molecular Biology Of Parana And Immunobiological Technology Institute To Develop Clinical Screening Systems 26 Sartorius Stedim Biotech Enters Into Co-Development Agreement With BD Diagnostic 27 NanoString Technologies And BD Biosciences Enter Into Agreement To Develop Single Cell Isolation And Analysis Workflow 28 TCGRx Enters Into Co-Marketing Agreement With CareFusion For Medication Delivery Solutions 30 CareFusion Enters Into Distribution Agreement With ResMed 31 SANYO North America Enters Into Co-Promotion Agreement With BD Biosciences 32 Accuri Cytometers Enters Into Co-Marketing Agreement With ebioscience 33 Bruker Daltonics And KIESTRA Enter Into Co-Marketing Agreement 34 Advanced Inhalation Therapies Enters into Licensing Agreement with CareFusion 35 BD Diagnostic Systems Enters Into Licensing Agreement With Lonza Group 36 Fate Therapeutics Enters Into Licensing Agreement With Becton, Dickinson 37 7
8 CareFusion Enters Into Licensing Agreement With Healthpoint 39 Eurogentec Enters Into Licensing Agreement With BD Diagnostics 40 Caliper Life Sciences Enters Into Licensing Agreement With BD Biosciences 41 Becton, Dickinson Files Registration Statement For Public Offering Of Securities 42 Becton, Dickinson Raises USD1.2 Billion in Public Offering of 4.685% Notes Due Becton, Dickinson Raises USD1.75 Billion in Public Offering of 3.734% Notes Due Becton, Dickinson Raises USD750 Million in Public Offering of Floating Rate Notes Due Becton, Dickinson Raises USD1.25 Billion in Public Offering of 2.675% Notes Due Becton, Dickinson Raises USD1.25 Billion in Public Offering of 1.8% Notes Due CareFusion Raises USD300 Million in Public Offering of Notes Due CareFusion Raises USD300 Million in Private Placement of Notes Due CareFusion Raises USD400 Million in Public Offering of Notes Due CareFusion Completes Private Placement Of Notes Due 2023 For US$300 Million 59 Becton, Dickinson Completes Public Offering Of Notes Due 2016 For US$500 Million 60 Becton, Dickinson Completes Public Offering Of Notes Due 2021 For US$1 Billion 61 Becton, Dickinson and Company Completes Underwritten Public Offering Of Senior Unsecured Notes Due 2040 For US$300 Million 63 Becton, Dickinson Completes Underwritten Public Offering Of Senior Unsecured Notes Due 2020 For US$700 Million 64 Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 65 eresearchtechnology Acquires Research Services Division From CareFusion 66 BD Acquires CRISI Medical Systems 68 Becton, Dickinson Acquires GenCell Biosystems 69 Becton, Dickinson Acquires Sirigen, Developer Of Polymer Dyes 70 Becton, Dickinson Acquires KIESTRA, Provider Of Lab Automation Solutions 72 CareFusion Completes Acquisition Of Medegen From Nautic Partners 73 Becton, Dickinson and Company, Key Competitors 75 Becton, Dickinson and Company, Key Employees 76 Becton, Dickinson and Company, Other Locations 78 Becton, Dickinson and Company, Subsidiaries 79 8
9 List Of Figures, Charts and Diagrams in Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD Becton, Dickinson and Company, Medical Devices Deals, 2010 to YTD
10 How to Buy... Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 10
Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
More informationConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business
More informationAcadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationStarpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationDNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research
More informationBionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and
More informationStarpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile
Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business
More informationNatera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business
More informationNorth China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationBessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
More informationKaro Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business
More informationGlenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationMedian Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
More informationMesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile
Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business
More informationPharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business
More informationEmcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
More informationCollegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business
More informationDaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector
More informationVanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector Publishing Intelligence Limited
More informationMesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile
Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business
More informationFaes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business
More informationBioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market
More informationMindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile
Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile BioPortfolio has
More informationParamount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile
Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Sector Publishing
More informationThe Walt Disney Company - Strategy, SWOT and Corporate Finance Report
The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Business Research Store is run by Sector Publishing Intelligence
More informationGap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Sector Publishing Intelligence
More informationKohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Sector Publishing Intelligence
More informationVorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report
Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report The Business Research Store is run by Sector Publishing Intelligence Ltd.
More informationMcCain Foods Limited, Inc. - Strategic SWOT Analysis Review
McCain Foods Limited, Inc. - Strategic SWOT Analysis Review McCain Foods Limited, Inc. - Strategic SWOT Analysis Review Sector Publishing Intelligence Limited (SPi) has been marketing business and market
More informationPhone: +44 (0) or BioPortfolio Limited
Global Laser Holographic Display Market by Product (Medical Scanners, Digital Signage, Kiosk, Notebook), by Application (Medical, Commercial, Industrial, Defense, Consumer Electronics), by Geography -
More informationMaruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment
More informationSurgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing
Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing Devices), and Sutures (Sutures by Type (Absorbable & Non-Absorbable),
More informationCompression Therapy - Medical Devices Pipeline Assessment, 2017
Compression Therapy - Medical Devices Pipeline Assessment, 2017 Compression Therapy - Medical Devices Pipeline Assessment, 2017 BioPortfolio has been marketing business and market research reports from
More informationCritical Limb Ischemia - Pipeline Review, H1 2017
Critical Limb Ischemia - Pipeline Review, H1 2017 Critical Limb Ischemia - Pipeline Review, H1 2017 BioPortfolio has been marketing business and market research reports from selected publishers for over
More informationJohnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile
Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business and market research
More informationPwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update
PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease
More informationBy Justin Dill, Jacob Lindamood, David Stauffer, Mihai Prisacariu, and Jamie Zikos
By Justin Dill, Jacob Lindamood, David Stauffer, Mihai Prisacariu, and Jamie Zikos Becton Dickinson Company Overview BD has been a player in the MedTech industry since it was founded in 1897, originally
More informationUnited States Sterilization Equipment Market Outlook to 2021
United States Sterilization Equipment Market Outlook to 2021 United States Sterilization Equipment Market Outlook to 2021 BioPortfolio has been marketing business and market research reports from selected
More informationWOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview
Strategic Advisory Services 2018 Firm Overview Our Foundational Principles Strategic Advice for Biopharmaceutical, Medical Technology and Life Science sectors A Focus on Strategic Thinking in the Context
More informationGenerics Series: Authorized Generics Analysis Stemming the Generics Tide
Generics Series: Authorized Generics Analysis Stemming the Generics Tide Report summary An overview of the authorized generics landscape, including drivers and resistors for both branded and generics players
More informationBecton Dickinson Executive Summary Problem
Justin Dill, Jacob Lindamood, David Stauffer, Mihai Prisacariu, and Jamie Zikos Professor Alia Crocker Strategic Problem Solving December 8 th 2015 Becton Dickinson Executive Summary Problem Becton Dickinson
More informationMara H. Rogers, Partner Norton Rose Fulbright
Mara H. Rogers Partner Norton Rose Fulbright US LLP New York T:+1 212 318 3206 F:+1 212 318 3400 mara.rogers@nortonrosefulbright.com vcard (+Outlook) Related services Corporate, M&A and securities Mergers
More informationHow attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners
How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners How attractive is the BioRegion of Catalonia for foreign investment? M ost
More informationDealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved.
Dealdoc Acquisition agreement for Gambro Baxter International Gambro Dec 04 2012 Acquisition agreement for Gambro Companies: Baxter International Gambro Announcement date: Dec 04 2012 Deal value, US$m:
More informationRoche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.
Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo 2011 Dr. Axel Braun F. Hoffmann La Roche Ltd. Content Roche Company Profile The IP Department Patent Filings Global Strategy Sales Overview IP
More informationVenture Capital Report
Venture Capital Report Europe 1Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included
More informationDigital Health Funding and M&A
Digital Health Funding and M&A 2018 Third Quarter and Nine Month Report Funding and Merger & Acquisition activity for the Digital Health sector http://www.mercomcapital.com 1 Copyright 2010-2016 Mercom
More informationMergers and Acquisitions/ Private Equity. Providing In-Depth Deal Coverage for Buyers, Sellers, and Investors. Attorney Advertising
Mergers and Acquisitions/ Private Equity Providing In-Depth Deal Coverage for Buyers, Sellers, and Investors Attorney Advertising In every transaction, business perspective informs our legal strategy.
More informationLife Sciences Tools, Diagnostics, & Services Q Industry Overview
Life Sciences Tools, Diagnostics, & Services Q4 2017 Industry Overview Life Sciences Tools, Diagnostics, & Services: Industry Overview Key Takeaways M&A activity has remained steady at high volumes of
More informationVenture Capital Report
Venture Capital Report Europe 3Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included
More informationOmeros Raises More Than $63 Million in Financing
Omeros Raises More Than $63 Million in Financing Seattle, WA February 12, 2007 Omeros today announced that it has raised in excess of $63 million in an oversubscribed Series E equity financing. New investors,
More informationVentureSource Europe -- 3Q 2014
Europe -- 3Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, and liquidity. The included charts and graphs offer a
More informationAMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014
Sector insights The healthcare market is highly complex with global products delivered through local services and channels. The healthcare value chain is intricate, diverse and interdependent. It is a
More informationPerspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond
Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,
More informationFall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE
Fall 2015 State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Industry Overview The expansion of Florida s biotech industry remains resilient with an overall growth rate of 92% in the number
More informationLife Sciences Outlook. New York City 2016
Life Sciences Outlook City 2016 City is emerging as a leading destination for biotech startups and the larger life sciences industry. Investors have committed millions of dollars throughout the city and
More informationCeQur establishes Wales subsidiary
FOR IMMEDIATE RELEASE CeQur establishes Wales subsidiary -- Arthurian Life Sciences investment helps bring to market world s first three-day simple insulin infusion device for type 2 diabetes -- LUCERNE,
More informationMaster Class : Excellence in Private Equity & Deal Structuring
Master Class : Excellence in Private Equity & Deal Structuring Program Description: A strong understanding of private equity and deal structuring has become a necessity for all players in the financial
More informationLife Sciences. An evolving industry: Today s clusters creating tomorrow s breakthroughs. Long Island JLL Research
Life Sciences Long Island 2017 An evolving industry: Today s clusters creating tomorrow s breakthroughs JLL Research Suffolk County Stony Brook University serves as an integral part of the research corridor
More informationNOT FOR DISTRIBUTION IN THE USA,CANADA, JAPAN OR AUSTRALIA
Press release Baar, 28 January 2008 Attractive portfolio of investments in biotech and medical technology to be opened to the public HBM BioVentures announces further information of its planned IPO on
More informationVenture Capital Report
Venture Capital Report China 1 Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included
More informationState of Licensing 2011 Update
State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-
More informationVenture Capital Report
Venture Capital Report China 2 Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included
More informationNew York Bar admission (or eligibility to obtain admission promptly) is required.
Job Opportunities To apply to any of the positions send cover letter referencing job opening with resume and salary requirements to info@bryantrabbino.com Senior Level Corporate Finance Attorney We are
More informationGLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT
GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT CRITICAL THINKING AT THE CRITICAL TIME ABOUT US The Global Risk and Investigations Practice (GRIP) of FTI Consulting is the leading provider of
More informationImplantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast,
Transparency Market Research Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 2018 Buy Now Request Sample Published Date: Mar 2013 Single User
More informationJOHN JACK R. TUPMAN, JR CURRICULUM VITAE
JOHN JACK R. TUPMAN, JR CURRICULUM VITAE September 2018 John R. Tupman, Jr. is a consultant focused on business development and licensing in the life sciences industry. He is currently working as a consultant
More informationPitchBook. Bet ter Data. Bet ter Decisions. 4Q 2012 Private Equity. Company Inventory. Report. Sponsored by:
4Q 2012 Private Equity Company Inventory Report Sponsored by: www.newstarfin.com Introduction In the last few quarters, an overwhelming number of the inquiries coming in to the Research Team have centered
More information2013 Global venture capital confidence survey results. How confident are investors?
2013 Global venture capital confidence survey results How confident are investors? August 14, 2013 Contents Survey methodology, demographics and key findings Economic trends Regional and country investing
More informationApril By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW
Global Transcatheter Aortic Valve Replacement (TAVR) Market: Analysis By Type of Approach (Transfemoral and Transapical), By Region, By Country: Opportunities and Forecast (2017-2022) By Type of Approach-
More informationRobert A. Greising Partner
Robert A. Greising Partner P: (317) 238-6215 F: (317) 636-1507 E: rgreising@kdlegal.com Indianapolis Office One Indiana Square Suite 2800 Indianapolis, IN 46204-2079 Robert Greising is a Partner in the
More informationWorld Offshore Wind Market Forecast Prospects, Technologies, World Markets
2016 World Offshore Wind Market Forecast 2016-2025 Prospects, Technologies, World Markets Contents Table of Contents 1 Summary and Conclusions...7 Summary... 8 Conclusions... 9 2 Drivers and Indicators...
More informationGlobal Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner
Global Source Ventures, LLC Introduction Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Introduction to Global Source Ventures GSV provides seed capital to emerging companies with emphasis
More informationSeptember 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board
AGENDA SPECIAL CALLED TELEPHONE MEETING of THE UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS September 18, 2017 Austin, Texas Page CONVENE THE BOARD IN OPEN SESSION TO RECESS TO EXECUTIVE SESSION PURSUANT
More informationDiscovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D.
Discovery: From Concept to the Patient - The Business of Medical Discovery Todd Sherer, Ph.D. Associate Vice President for Research and Director of OTT President Elect, Association of University Technology
More informationThe Shape of Things to Come: Massachusetts June 18, 2010 Newton Marriott Hotel
The Shape of Things to Come: Massachusetts 2020 June 18, 2010 Newton Marriott Hotel Mark Nemec, Ph.D Managing Director, Technology Industry Client Group Forrester Research Some Thoughts on The Reset Economy
More informationLocal Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background
Local Production of Pharmaceuticals and Related Technology Transfer Dr. Padmashree Gehl Sampath Division for Technology and Logistics UNCTAD UNCTAD/CD-TFT 1 1 Background Case studies part of the EU funded
More informationTrends in Healthcare Investments and Exits 2018
Trends in Healthcare Investments and Exits 208 208 Massachusetts Life Science Innovation Day Clark Hayes Managing Director Life Science/Healthcare Northeast Head of Business Development SVB Corporate Overview
More informationLife Sciences Outlook. Long Island 2016
Life Sciences Outlook Long Island 2016 Long Island The Long Island life sciences landscape will continue to fuel the economy as firms emerge from Cold Spring Harbor Laboratory in Nassau County, as well
More informationData-Driven Evaluation: The Key to Developing Successful Pharma Partnerships
R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is
More informationVenture Capital Report
Europe 4Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs
More informationHBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio
HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio SECA conference Zurich, 3 July 2013 Dr. Andreas Wicki, CEO HBM at a Glance SIX-listed investment company
More informationLicensing League Tables 3Q14
BioPharm Insight Licensing League Tables Table of Contents League Tables Global League Tables of Legal Advisors for...2 Global League Tables of Legal Advisors for...3 North American League Tables of Legal
More informationChartwell Introduction and AEC Capabilities
Chartwell Introduction and AEC Capabilities Comprehensive Financial Advisory Experience Chartwell provides financial advisory solutions to the middle market; areas of expertise include corporate finance,
More informationA Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei
A Brief Introduction to the Regulatory Environment of Medical Device Supervision CFDA Department of Legal Affairs Liu Pei Development Trend of Medical Device Industry Development Opportunities of Medical
More informationNasir, Dao PKM Abdul Partner PwC Legal (Vietnam) Co., Ltd
Nasir, Dao PKM Abdul Partner PwC Legal (Vietnam) Co., Ltd Get in touch Tel. (direct): +84 (8) 3824 0109 nasir.pkm@pwc.com Professional profile Nasir is a partner and the Legal Services Leader in Vietnam.
More informationGerresheimer CAPITAL MARKETS DAY 2010
Gerresheimer CAPITAL MARKETS DAY 2010 Gerresheimer Today September 1, 2010 Uwe Röhrhoff, CEO Gerresheimer who we are and what we do Gerresheimer is an important partner of the pharmaceutical and healthcare
More informationVALUATION TRENDS 18.8
SPOT ON TESTING, INSPECTION & CERTIFICATION Arjen Kostelijk, Oaklins' Testing, Inspection & Certification (TIC) specialist, is pleased to share some highlevel industry intelligence in this edition of Spot
More informationAsia Pacific UK Cross border transactions. Corporate Finance PRECISE. PROVEN. PERFORMANCE.
Asia Pacific UK Cross border transactions PRECISE. PROVEN. PERFORMANCE. Cross border transactions Our services Moore Stephens global network of offices allows us to combine expert knowledge and advice
More informationAqua Pharmaceuticals, LLC
Aqua Pharmaceuticals, LLC Corporate Presentation June 2011 AQUA PHARMACEUTICALS, LLC 1 Company Overview Specialty dermatology pharmaceutical company currently focusing on acquiring, developing and marketing
More informationRobert A. Greising Partner
Robert A. Greising Partner P: (317) 238-6215 F: (317) 636-1507 E: rgreising@kdlegal.com Indianapolis Office One Indiana Square Suite 2800 Indianapolis, IN 46204-2079 Robert Greising serves as a Partner
More informationBayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division
Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your
More informationFinancing SMEs and Entrepreneurs 2012
Financing SMEs and Entrepreneurs 2012 AN OECD SCOREBOARD OECD Table of Contents Acronyms and abbreviations 13 Chapter 1. Financing SMEs and Entrepreneurs: Understanding and Developing an OECD Scoreboard
More informationCommercialization Strategies that Work
Commercialization Strategies that Work Jenny C. Servo, Ph.D. DAWNBREAKER (585)594-0025 DAWNBREAKER Professional Services firm - Rochester, NY Worked with over 1200 SBIR/STTR firms - Department of Energy,
More informationJanuary Bob DeSutter Managing Director Co-Head of Health Care
January 2007 Dear Friends and Clients, For much of our 112 year history, serving innovative health care companies has been an important part of our mission at Piper Jaffray. Our goal is to be lead advisor
More informationI Overview. II Hallmarks of Turnpoint Group. III Corporate Financial Services. IV Assignments. V Clients. VI Market Segments
Content I Overview II Hallmarks of Turnpoint Group III Corporate Financial Services IV Assignments V Clients VI Market Segments VII Selection of transactions a. advising the seller b. advising the buyer
More informationCHINA MED DEVICE. China Medtech Will Continue Its Double Digit Growth in Years to Come
China Medtech Will Continue Its Double Digit Growth in Years to Come The high level characteristics of medtech in China is focused here. Each of the 6 specific sectors according to SWS recommendation will
More informationCannabis Practice Group
Cannabis Practice Group McMillan LLP Vancouver Calgary Toronto Ottawa Montréal Hong Kong Cannabis mcmillan.ca Practice Group 1 Medical cannabis is booming and McMillan is at the forefront of developments
More information2 nd Quarter Earnings Conference Call
2 nd Quarter Earnings Conference Call KKR & Co. Inc. Investor Update July 26, 2018 Recent Milestones K-1 $ Converted to a Corporation on July 1, 2018 Investor Day held on July 9, 2018 2 Key Metrics Assets
More informationgellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) Web gellerbp.
gellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) 315-0600 Web gellerbp.com Summary Personal Diverse, world-class team of top biotech bankers,
More information